Blog
About

  • Record: found
  • Abstract: found
  • Article: found
Is Open Access

Stigmatisation and body image impairment in dermatological patients: protocol for an observational multicentre study in 16 European countries

Read this article at

Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      Introduction

      Patients with common skin diseases may have substantial psychosocial comorbidity and reduced quality of life. This study aims at exploring further the psychosocial burden of skin diseases by assessing stigmatisation and body image problems in a large sample of patients with skin disease across Europe.

      Methods and analysis

      The study is an observational cross-sectional multicentre study across 16 European countries comparing stigmatisation and body image in patients with skin disease compared with controls. Consecutive patients will be recruited in outpatient clinics and will complete validated questionnaires prior to clinical examination by a dermatologist at each recruitment site. In addition to sociodemographic background information, the outcomes will be: mood disorders assessed by short versions of the Patient Health Questionnaire and the General Anxiety Disorder Assessment; general health assessed by the EuroQol-Visual Analogue Scale; stigmatisation experience assessed by the Perceived Stigmatisation Questionnaire; stress assessed by the Perceived Stress Scale and body image assessed by the Dysmorphic Concern Questionnaire. The main criteria for eligibility are to be 18 years old or more. The analysis will include comparison between patients and controls for the main outcomes using t-tests, analyses of covariance and multivariate logistic regression models adjusting for potential confounding factors.

      Ethics and dissemination

      The study protocol is approved by the University of Giessen and by the local Ethical Committee in each recruitment centre. Informed consent will be given by each participant. The results of the study will be disseminated by publications in international peer-reviewed journals and presented at international conferences and general public conferences. Results will influence support intervention and management of patients with skin disease across Europe.

      Trial registration number

      DRKS00012745; Pre-results.

      Related collections

      Most cited references 32

      • Record: found
      • Abstract: not found
      • Article: not found

      A Global Measure of Perceived Stress

        Bookmark
        • Record: found
        • Abstract: found
        • Article: not found

        The Global Burden of Cancer 2013.

        Cancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies.
          Bookmark
          • Record: found
          • Abstract: found
          • Article: not found

          The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review.

          Depression, anxiety and somatization are the most common mental disorders in primary care as well as medical specialty populations; each is present in at least 5-10% of patients and frequently comorbid with one another. An efficient means for measuring and monitoring all three conditions would be desirable. Evidence regarding the psychometric and pragmatic characteristics of the Patient Health Questionnaire (PHQ)-9 depression, generalized anxiety disorder (GAD)-7 anxiety and PHQ-15 somatic symptom scales are synthesized from two sources: (1) four multisite cross-sectional studies (three conducted in primary care and one in obstetric-gynecology practices) comprising 9740 patients, and (2) key studies from the literature that have studied these scales. The PHQ-9 and its abbreviated eight-item (PHQ-8) and two-item (PHQ-2) versions have good sensitivity and specificity for detecting depressive disorders. Likewise, the GAD-7 and its abbreviated two-item (GAD-2) version have good operating characteristics for detecting generalized anxiety, panic, social anxiety and post-traumatic stress disorder. The optimal cutpoint is > or = 10 on the parent scales (PHQ-9 and GAD-7) and > or = 3 on the ultra-brief versions (PHQ-2 and GAD-2). The PHQ-15 is equal or superior to other brief measures for assessing somatic symptoms and screening for somatoform disorders. Cutpoints of 5, 10 and 15 represent mild, moderate and severe symptom levels on all three scales. Sensitivity to change is well-established for the PHQ-9 and emerging albeit not yet definitive for the GAD-7 and PHQ-15. The PHQ-9, GAD-7 and PHQ-15 are brief well-validated measures for detecting and monitoring depression, anxiety and somatization. Copyright 2010. Published by Elsevier Inc.
            Bookmark

            Author and article information

            Affiliations
            [1 ] departmentDepartment of Dermatology and Venereology , Skåne University Hospital , Malmo, Sweden
            [2 ] National Centre for Dual Diagnosis, Innlandet Hospital Trust , Brumunddal, Norway
            [3 ] departmentDepartment of Dermatology , Barts Health NHS Trust , London, UK
            [4 ] departmentDepartment of Health, Medical and Neuropsychology , Faculty of Social and Behavioral Science , Leiden, The Netherlands
            [5 ] departmentDepartment of Dermatology , Justus Liebig University , Giessen, Germany
            [6 ] departmentClinical Epidemiology Unit , Istituto Dermopatico dell’Immacolata , Rome, Italy
            [7 ] departmentCenter for Chronic Pruritus and Department of Dermatology , University Hospital Münster , Münster, Germany
            [8 ] departmentDepartment of Psychology , University of Zaragoza , Zaragoza, Spain
            [9 ] departmentDepartment of Psychiatry , Academic Medical Hospital , Amsterdam, The Netherlands
            [10 ] Institute of Medical Psychology, Justus Liebig University , Giessen, Germany
            Author notes
            [Correspondence to ] Dr Florence J Dalgard; florikje@ 123456gmail.com
            Journal
            BMJ Open
            BMJ Open
            bmjopen
            bmjopen
            BMJ Open
            BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
            2044-6055
            2018
            22 December 2018
            : 8
            : 12
            30580274
            6307615
            bmjopen-2018-024877
            10.1136/bmjopen-2018-024877
            © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

            This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

            Product
            Categories
            Dermatology
            Protocol
            1506
            1687
            Custom metadata
            unlocked

            Medicine

            burden of disease, dermatological epidemiology, stigmatisation, body image

            Comments

            Comment on this article